Get software! [General Sta­tis­tics]

posted by verstc – China, 2018-06-17 14:55 (1435 d 18:40 ago) – Posting: # 18910
Views: 4,741

Dear Helmut,

Thanks a lot for your reply.

It is clear to me for your explain.

I am wondering if there is a way to reduce the intra-subject CV. I think intra-subject CV is an inherent characteristic of a drug. is it right? If it not, does anyone can reduce it by any ways?

Thanks,

best,
Shawn


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,091 posts in 4,630 threads, 1,566 registered users;
online 5 (1 registered, 4 guests [including 4 identified bots]).
Forum time: Monday 09:36 CEST (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5